What sets Foundayo apart from other GLP-1s is that its a small molecule drug the first GLP-1 in this category that can easily enter the bloodstream through the digestive system, even right after a meal
Both medications had similar gastrointestinal side effects
The SUSTAIN Trials: A Weight Loss Plot Twist Now, picture this
More real world data suggests that GLP-1 drugs, which are reputed to aid the bodys cancer killing cells, may reduce the risk of colorectal, prostate, and liver cancer, too, says Drucker
To put this in perspective, the FDA approval of Ozempic was based on evidence from seven clinical trials with over 4,000 participants in 33 different countries
Louis found that GLP-1 medications were associated with lower risks of developing substance use disorders involving alcohol, nicotine, cannabis, cocaine, opioids, and other substances